第一作者单位:[1]Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Peoples R China[2]Henan Canc Hosp, Zhengzhou, Peoples R China[3]Zhengzhou Univ, Dept Oncol, Affiliated Hosp 1, Zhengzhou, Peoples R China[4]Shenyou Bio, Clin Labs, Zhengzhou, Peoples R China[5]Yancheng 1 Peoples Hosp, Yancheng, Peoples R China[6]China Japan Friendship Hosp, Beijing, Peoples R China[7]SeekIn Inc, Shenzhen, Peoples R China[8]Henan Prov Peoples Hosp, Zhengzhou, Peoples R China
推荐引用方式(GB/T 7714):
Lyu Xiaodong,Li Tao,Zhu Dandan,et al.Whole-genome sequencing as an alternative to analyze copy number abnormalities in AML, MDS and MM[J].JOURNAL OF CLINICAL ONCOLOGY.2022,40(16):E19023-E19023.
APA:
Lyu, Xiaodong,Li, Tao,Zhu, Dandan,Cheng, Yuexin,He, Xiangxiang...&Song, Yongping.(2022).Whole-genome sequencing as an alternative to analyze copy number abnormalities in AML, MDS and MM.JOURNAL OF CLINICAL ONCOLOGY,40,(16)
MLA:
Lyu, Xiaodong,et al."Whole-genome sequencing as an alternative to analyze copy number abnormalities in AML, MDS and MM".JOURNAL OF CLINICAL ONCOLOGY 40..16(2022):E19023-E19023